Cancer Immunity (28 August 2008) Vol. 8, p. 13

Cancer Immunity (24 April 2008) Vol. 8, p. 8

1Department of Microbiology and Immunology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, TX, USA 2Division of Hematology & Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, TX, USA 3Kiromic Inc., Lubbock, TX, USA 4Norris Comprehensive Cancer Center and Departments of Mo...

Cover vol. 12, no.4, August 2015-

Cancer Immunity (27 March 2008) Vol. 8, p. 6

1Multidisciplinary Oncology Center, University of Lausanne Hospitals (CHUV), Lausanne, Switzerland 2Department of Radio-Oncology, CHUV, Lausanne, Switzerland 3Division of Experimental Oncology, Multidisciplinary Oncology Center, CHUV, Lausanne, Switzerland 4Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland 5Department of Pathology...

Cancer Immunity (13 August 2007) Vol. 7, p. 12

Significant work in animal models combined with compelling studies in human patients together have begun to provide a higher resolution picture of how the immune system regulates cancer development. Currently, this immune system-tumor interaction is represented by the concept of cancer immunoediting, which emphasizes that immunity may subserve either classical cancer immunosurveillance function...

Cancer Immunity (15 January 2013) Vol. 13, p. 3

1Department of Oncology, University Hospital Zürich, Zürich, Switzerland 2CT-Atlantic, Schlieren, Switzerland 3Ludwig Institute for Cancer Research, New York Branch, Memorial Sloan-Kettering Cancer Center, New York, NY, USA 4Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan 5Departments of Cancer Vaccine and Immuno-Gene Therapy, Mie University Graduate...